BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Uncategorized » Metabolic derangements caused by a high-fat diet may be possible to eliminate

Metabolic derangements caused by a high-fat diet may be possible to eliminate

Intake of a high-fat diet leads to an increased risk for obesity, type 2 diabetes, cardiovascular diseases and fatty liver. A study in mice from Karolinska Institutet shows that it is possible to eliminate the deleterious effects of a high-fat diet by lowering the levels of apolipoprotein CIII (apoCIII), a key regulator of lipid metabolism. The study is published in the journal Science Advances.

 

Read more:

  • Press release in English
  • Science Advances, 12 Mar 2021, vol. 7, no. 11, eabc2931

 

March 15, 2021 Christel Ågren

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications March 8, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022
  • Kallelse till årsstämma 22 juni 2021
    Kallelse till årsstämma 22 juni 2021 May 19, 2021
  • Metabolic derangements caused by a high-fat diet may be possible to eliminate
    Metabolic derangements caused by a high-fat diet may be possible to eliminate March 15, 2021
  • Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye
    Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye November 28, 2019
  • Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours
    Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours November 18, 2019
  • Novel findings explain indirect regulation of glucose homeostasis
    Novel findings explain indirect regulation of glucose homeostasis August 21, 2019
  • Transplanted cells reveal early signs of type 1 diabetes
    Transplanted cells reveal early signs of type 1 diabetes May 15, 2019
  • ERC grant for research on insulin-producing cells
    ERC grant for research on insulin-producing cells April 1, 2019

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved